Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06358742
Other study ID # ORL-GUM-2787
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 10, 2017
Est. completion date May 19, 2017

Study information

Verified date March 2023
Source Unilever R&D
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is of a double-blind, randomised, parallel group study. Subjects will be enrolled onto the study according to the inclusion/exclusion criteria. After recruitment, subjects will be given a fluoride toothpaste without gum care agents to use for the 4-week run-in period prior to the commencement of the test phase of the study. Following the run-in period, baseline supragingival plaque samples will be collected 12 hours after last brushing, from the upper and lower jaws separately. Subjects will then then randomly allocated to one of two products (zinc citrate trihydrate [ZCT] toothpaste or control toothpaste) according to the randomization. Subjects will be instructed to use the toothpaste at home, brushing twice a day for 12-weeks. Supragingival plaque samples will be collected again from the upper and lower jaws after 2, 6 and 12 weeks. Plaque samples will then undergo metataxonomic and metatranscriptomic analyses.


Description:

This study is a double-blind, randomized, parallel group study and will be conducted by an independent clinical research organisation. Subjects will be enrolled onto the study according to the inclusion/exclusion criteria. After recruitment, subjects will be given a fluoride toothpaste without gum care agents to use for the 4-week run-in period prior to the commencement of the test phase of the study. This phase of the study is to ensure that all subjects are standardized to a fluoride only toothpaste. Following the run-in period, baseline supragingival plaque samples will be collected 12 hours after last brushing, from the upper and lower jaws separately, for metataxonomic and metatranscriptomic analysis respectively. Subjects will be randomly allocated to one of two products (zinc citrate trihydrate toothpaste/control toothpaste) according to the randomization schedule generated using Proc Plan procedure in SAS 9.4 suitable for 2-group parallel design study. Subjects will be instructed to use the toothpaste at home, brushing twice a day for 12-weeks. Supragingival plaque samples will be collected again from the upper and lower jaws after 2, 6 and 12 weeks. Samples are to be collected by a single clinician across the study to ensure consistency in sample collection. (Note: The study clinician could not collect samples at week 12 because of sickness. Different clinicians collected the samples instead. Data analysis showed that the week 12 samples did not match the week 0, 2 and 6 samples [higher levels of DNA indicative of different sample collection] and hence they were excluded from the analysis).


Recruitment information / eligibility

Status Completed
Enrollment 142
Est. completion date May 19, 2017
Est. primary completion date May 19, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Healthy, adult, male/female volunteers - Aged between 18 and 65 years old - Willing to sign an informed consent and complete a medical history questionnaire - Have at least 20 natural teeth including 5 teeth (excluding 3rd molars) in each quadrant - Must be available for the duration of the study Exclusion Criteria: - The subject is an employee of Unilever or the site conducting the study - Subjects taking part in other oral care studies for the Sponsor or any other company - Smokers (including eCigarettes) or those who have smoked in the preceding 12 months. - Subjects showing unwillingness, inability or lack of motivation to carry out the study procedures - Subjects who are pregnant or nursing - Subjects who have used mouthwashes within the 4 weeks prior to the start of the study. - Subjects with a Modified Gingival Index score of 3 at screening - Diabetics - Subjects showing signs of early or untreated caries or significant periodontal disease, which in the opinion of the Study Dentist, would affect either the scientific validity of the study or, if the subject was to participate in the study, would affect their wellbeing. - Subjects who have full or partial dentures or any oral piercings - Subjects who have an active oral herpetic lesion or regularly suffer with oral herpetic lesions - Subjects who regularly use medication or food supplements (including supplements which contain Zinc) in the 4 weeks prior to the start of the study, or during the study - Subjects who have or have had a medical or oral condition which in the opinion of the study dentist would make them unsuitable for inclusion - Known allergies to the toothpaste ingredients or to any dental materials - Taking a course of antimicrobial medication within 4 weeks of screening or during the study - Long term use of anti-inflammatory and/or antihistamine drugs. Intermittent use is permitted apart from 24 hours prior to the assessments

Study Design


Related Conditions & MeSH terms


Intervention

Other:
ZCT toothpaste

Control toothpaste


Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
Unilever R&D Intertek

Outcome

Type Measure Description Time frame Safety issue
Primary Plaque microbiome Speciation of plaque bacteria 6 weeks
See also
  Status Clinical Trial Phase
Completed NCT04881357 - Antiplaque/Antigingivitis Effect of Lacer Oros Integral N/A
Completed NCT04561960 - Efficacy of Miswak in Oral Hygiene Maintenance Phase 4
Completed NCT04025684 - Efficacy of Manual Toothbrushes in Removing Dental Plaque N/A
Completed NCT03394729 - Effect of a Propolis Tablet on the Saliva and the Amount of Adolescent Dental Plaque Microbes Phase 2/Phase 3
Completed NCT05187507 - Effectiveness of Theobromine Toothpaste N/A
Completed NCT04485520 - Efficacy of the Extract of Carica Papaya as an Inhibitor of Streptococcus Mutans N/A
Completed NCT02552589 - Effect of Toothpaste on the Reduction of Plaque and Inflammation N/A
Completed NCT02884817 - Essential Oil+ELA, Plaque and Gingivitis Phase 4
Completed NCT02194023 - Clinical Effects of Two New Chlorhexidine Digluconate Formulations: 0.12% and 0.03%. Phase 2
Completed NCT01237782 - Efficacy of a Propolis-based Denture Cleanser N/A
Completed NCT00758394 - Clinical Study to Compare Dental Plaque Control Phase 3
Completed NCT00254345 - Effect of Provisional-Crown Surface Coating on Biofilm Formation Phase 1
Completed NCT05579938 - Effect of Enzymes on Dental Biofilm Accumulation N/A
Completed NCT05038293 - Efficacy of Plaque Removal of a Novel Brushing Device N/A
Terminated NCT05082103 - Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals N/A
Not yet recruiting NCT06081868 - RCT on Effectiveness of Oral Health Preventive Programmes in School Children in Uganda N/A
Completed NCT05853679 - Regular Antibacterial Photodynamic Therapy on Oral Hygiene in Elderly Residents N/A
Completed NCT05521230 - Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software Phase 1
Completed NCT03311438 - Oral Health Intervention Program for Children With Congenital Heart Defects N/A
Enrolling by invitation NCT06122636 - Efficacy of a Probiotic and Microbiological Analysis on Oral Complications Induced by Antineoplastic Therapies in Patients With HNC N/A